Pier Capital’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
Pier Capital's MRVI Position: Q3 2026 in Review
Pier Capital opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 555,079 shares worth $4.25M. The stake represents 0.62% of the portfolio and ranks #78 among its holdings. This is a return to the name: Pier Capital previously reported a position in MRVI as recently as Q4 2024.
Pier Capital first reported a position in MRVI in Q4 2021 and has held it in 14 quarters since. The position peaked at $6.15M in Q4 2024. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Pier Capital held 555,079 shares of Maravai LifeSciences worth $4.25M as of Q3 2026.
- Maravai LifeSciences was a new Pier Capital position in Q3 2026.
- Maravai LifeSciences made up 0.62% of Pier Capital's portfolio in Q3 2026, its #78 holding.
- Pier Capital first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 14 quarters since.
- Pier Capital's Maravai LifeSciences position peaked at $6.15M in Q4 2024.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Pier Capital's 13F filing for Q3 2026, filed 13 Nov 2026.